{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T16:37:23Z","timestamp":1773419843919,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Densitometry"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.jocd.2009.12.004","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T14:02:20Z","timestamp":1269957740000},"page":"237-244","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Longitudinal Study of Body Composition of 101 HIV Men With Lipodystrophy: Dual-Energy X-Ray Criteria for Lipodystrophy Evolution"],"prefix":"10.1016","volume":"13","author":[{"given":"Emilie","family":"Degris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrille","family":"Delpierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Sommet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e8phane","family":"Sire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slim","family":"Lassoued","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Aquilina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Marchou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrice","family":"Massip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Obadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Marion-Latard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jocd.2009.12.004_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1385\/JCD:8:3:287","article-title":"Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy","volume":"8","author":"Bonnet","year":"2005","journal-title":"J Clin Densitom"},{"issue":"3","key":"10.1016\/j.jocd.2009.12.004_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1385\/JCD:8:3:293","article-title":"Reproducibility of DXA estimations of body fat in HIV lipodystrophy: implications for clinical research","volume":"8","author":"Cavalcanti","year":"2005","journal-title":"J Clin Densitom"},{"issue":"7","key":"10.1016\/j.jocd.2009.12.004_bib3","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"issue":"9106","key":"10.1016\/j.jocd.2009.12.004_bib4","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jocd.2009.12.004_bib5","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1086\/339866","article-title":"Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy","volume":"34","author":"Saves","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.jocd.2009.12.004_bib6","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"issue":"Suppl 2","key":"10.1016\/j.jocd.2009.12.004_bib7","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1086\/313854","article-title":"HIV protease inhibitor-related lipodystrophy syndrome","volume":"30","author":"Carr","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"13","key":"10.1016\/j.jocd.2009.12.004_bib8","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A\u00a0syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint-Marc","year":"1999","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.jocd.2009.12.004_bib9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1001\/jama.288.2.207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial","volume":"288","author":"Carr","year":"2002","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jocd.2009.12.004_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"issue":"16","key":"10.1016\/j.jocd.2009.12.004_bib11","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/01.aids.0000247574.33998.03","article-title":"A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy","volume":"20","author":"Moyle","year":"2006","journal-title":"AIDS"},{"issue":"6","key":"10.1016\/j.jocd.2009.12.004_bib12","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1310\/hct0806-381","article-title":"The safety and efficacy of switching stavudine to tenofovir df in combination with lamivudine and efavirenz in hiv-1-infected patients: three-year follow-up after switching therapy","volume":"8","author":"Madruga","year":"2007","journal-title":"HIV Clin Trials"},{"issue":"1","key":"10.1016\/j.jocd.2009.12.004_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1468-1293.2005.00334.x","article-title":"Pronounced lipoatrophy in HIV-infected men receiving HAART for more than 6 years compared with the background population","volume":"7","author":"Hansen","year":"2006","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.jocd.2009.12.004_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1310\/EJRF-JGGH-GRCD-MED8","article-title":"Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir versus continued HAART: the Trizal study","volume":"4","author":"Lafeuillade","year":"2003","journal-title":"HIV Clin Trials"},{"issue":"12","key":"10.1016\/j.jocd.2009.12.004_bib15","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jocd.2009.12.004_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1468-1293.2005.00305.x","article-title":"Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive","volume":"6","author":"Bergersen","year":"2005","journal-title":"HIV Med"},{"key":"10.1016\/j.jocd.2009.12.004_bib17","unstructured":"Moyle G. [Poster 938]. CROI. 2008."},{"key":"10.1016\/j.jocd.2009.12.004_bib18","unstructured":"Martinez E. International AIDS Conference [MOPDB 102]. Mexico 2008."},{"issue":"2","key":"10.1016\/j.jocd.2009.12.004_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.qai.0000182230.47819.aa","article-title":"Fat distribution in men with HIV infection","volume":"40","author":"Bacchetti","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.jocd.2009.12.004_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study","volume":"14","author":"Saint-Marc","year":"2000","journal-title":"AIDS"},{"issue":"22","key":"10.1016\/j.jocd.2009.12.004_bib21","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/archinte.162.22.2621","article-title":"Incidence of adipose tissue alterations in first-line antiretroviral therapy: the LipoICoNa Study","volume":"162","author":"Galli","year":"2002","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.jocd.2009.12.004_bib22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/135965350501000105","article-title":"Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.jocd.2009.12.004_bib23","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1592\/phco.26.2.154","article-title":"Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry","volume":"26","author":"Tavassoli","year":"2006","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.jocd.2009.12.004_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1086\/589622","article-title":"A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy","volume":"198","author":"Cameron","year":"2008","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.jocd.2009.12.004_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1468-1293.2008.00606.x","article-title":"Recovery of fat\u00a0following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke Trial","volume":"9","author":"Valantin","year":"2008","journal-title":"HIV Med"},{"issue":"5","key":"10.1016\/j.jocd.2009.12.004_bib26","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/jac\/dkm029","article-title":"Exploratory study comparing the metabolic toxicities of a lopinavir\/ritonavir plus saquinavir dual protease inhibitor regimen versus a lopinavir\/ritonavir plus zidovudine\/lamivudine nucleoside regimen","volume":"59","author":"Cameron","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.jocd.2009.12.004_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1310\/4X0H-UVMJ-BHYW-CPFB","article-title":"Relationship between low bone mineral density and highly active antiretroviral therapy including protease inhibitors in HIV-infected patients","volume":"4","author":"Fernandez-Rivera","year":"2003","journal-title":"HIV Clin Trials"},{"issue":"1","key":"10.1016\/j.jocd.2009.12.004_bib28","first-page":"39","article-title":"Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy","volume":"48","author":"Madeddu","year":"2004","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.jocd.2009.12.004_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1468-1293.2005.00278.x","article-title":"Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients","volume":"6","author":"Seminari","year":"2005","journal-title":"HIV Med"},{"issue":"3","key":"10.1016\/j.jocd.2009.12.004_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"issue":"17","key":"10.1016\/j.jocd.2009.12.004_bib31","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.jocd.2009.12.004_bib32","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.jocd.2009.12.004_bib33","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/JBMR.0301246","article-title":"BMD is reduced in HIV-infected men irrespective of treatment","volume":"19","author":"Amiel","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.jocd.2009.12.004_bib34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2265.2006.02572.x","article-title":"Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy","volume":"65","author":"Bolland","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"8","key":"10.1016\/j.jocd.2009.12.004_bib35","first-page":"407","article-title":"Bone mineral abnormalities in persons with HIV infection: signal or noise?","volume":"16","author":"Singh","year":"2006","journal-title":"AIDS Read"},{"issue":"2","key":"10.1016\/j.jocd.2009.12.004_bib36","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2265.2007.02875.x","article-title":"Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years","volume":"67","author":"Bolland","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jocd.2009.12.004_bib37","unstructured":"Bonnet E, Mabile L, Ruidavets JB, et\u00a0al. Important changes in bone metabolism soon after commencing HAART. [Poster] 9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV. Sydney; 2007."},{"key":"10.1016\/j.jocd.2009.12.004_bib38","unstructured":"Duvivier C, Kolta S, Assoumou L, et\u00a0al. First-line PI-containing regimens enhance decreased bone mineral density greater than NNRTI-containing regimen in HIV-1 infected patients: a substudy of the HIPPOCAMPE-ANRS 121 trial. [Abstract] Proceedings of the 15th Conference on Retroviruses and Opportunistic Infections. Boston; 2008."},{"issue":"8","key":"10.1016\/j.jocd.2009.12.004_bib39","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1097\/00002030-200105250-00005","article-title":"Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy","volume":"15","author":"Huang","year":"2001","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jocd.2009.12.004_bib40","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/135965350701200701","article-title":"The association of bone mineral density with HIV infection and antiretroviral treatment in women","volume":"12","author":"Anastos","year":"2007","journal-title":"Antivir Ther"},{"issue":"3","key":"10.1016\/j.jocd.2009.12.004_bib41","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jc.2003-031506","article-title":"Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia","volume":"89","author":"Brown","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Clinical Densitometry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469500900273X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109469500900273X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:36:11Z","timestamp":1761082571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109469500900273X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S109469500900273X"],"URL":"https:\/\/doi.org\/10.1016\/j.jocd.2009.12.004","relation":{},"ISSN":["1094-6950"],"issn-type":[{"value":"1094-6950","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Study of Body Composition of 101 HIV Men With Lipodystrophy: Dual-Energy X-Ray Criteria for Lipodystrophy Evolution","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Densitometry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocd.2009.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The International Society for Clinical Densitometry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}